{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T01:34:57Z","timestamp":1718069697811},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,12]]},"DOI":"10.7759\/cureus.48683","type":"journal-article","created":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T11:37:14Z","timestamp":1699789034000},"source":"Crossref","is-referenced-by-count":1,"title":["Metformin-Associated Lactic Acidosis in Individuals Without Chronic Kidney Disease on Therapeutic Dose: A Case Report"],"prefix":"10.7759","author":[{"given":"Masafumi","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhisa","family":"Hirayu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Nabeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Takasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190519","article-title":"Serum lactate upon emergency department arrival as a predictor of 30-day in-hospital mortality in an unselected population","volume":"13","author":"Park YJ","year":"2018","unstructured":"Park YJ, Kim DH, Kim SC, et al.. Serum lactate upon emergency department arrival as a predictor of 30-day in-hospital mortality in an unselected population. PLoS One. 2018, 13:10.1371\/journal.pone.0190519","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2019.06.027","article-title":"Demystifying lactate in the emergency department","volume":"75","author":"Wardi G","year":"2020","unstructured":"Wardi G, Brice J, Correia M, Liu D, Self M, Tainter C. Demystifying lactate in the emergency department. Ann Emerg Med. 2020, 75:287-98. 10.1016\/j.annemergmed.2019.06.027","journal-title":"Ann Emerg Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2013.860985","article-title":"Metformin accumulation: lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy","volume":"52","author":"Vecchio S","year":"2014","unstructured":"Vecchio S, Giampreti A, Petrolini VM, et al.. Metformin accumulation: lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy. Clin Toxicol (Phila). 2014, 52:129-35. 10.3109\/15563650.2013.860985","journal-title":"Clin Toxicol (Phila)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.0292","article-title":"Association of metformin use with risk of lactic acidosis across the range of kidney function: a community-based cohort study","volume":"178","author":"Lazarus B","year":"2018","unstructured":"Lazarus B, Wu A, Shin JI, et al.. Association of metformin use with risk of lactic acidosis across the range of kidney function: a community-based cohort study. JAMA Intern Med. 2018, 178:903-10. 10.1001\/jamainternmed.2018.0292","journal-title":"JAMA Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-012-0278-3","article-title":"Metformin-associated lactic acidosis (MALA): case files of the Einstein Medical Center medical toxicology fellowship","volume":"9","author":"Kopec KT","year":"2013","unstructured":"Kopec KT, Kowalski MJ. Metformin-associated lactic acidosis (MALA): case files of the Einstein Medical Center medical toxicology fellowship. J Med Toxicol. 2013, 9:61-6. 10.1007\/s13181-012-0278-3","journal-title":"J Med Toxicol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2337\/dci18-0033","article-title":"Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"41","author":"Davies MJ","year":"2018","unstructured":"Davies MJ, D'Alessio DA, Fradkin J, et al.. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018, 41:2669-701. 10.2337\/dci18-0033","journal-title":"Diabetes Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.6.925","article-title":"Incidence of lactic acidosis in metformin users","volume":"22","author":"Stang M","year":"1999","unstructured":"Stang M, Wysowski DK, Butler-Jones D. Incidence of lactic acidosis in metformin users. Diabetes Care. 1999, 22:925-7. 10.2337\/diacare.22.6.925","journal-title":"Diabetes Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12974","article-title":"Metformin-associated lactic acidosis (MALA): moving towards a new paradigm","volume":"19","author":"Lalau JD","year":"2017","unstructured":"Lalau JD, Kajbaf F, Protti A, Christensen MM, De Broe ME, Wiernsperger N. Metformin-associated lactic acidosis (MALA): moving towards a new paradigm. Diabetes Obes Metab. 2017, 19:1502-12. 10.1111\/dom.12974","journal-title":"Diabetes Obes Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-221686","article-title":"Metformin-associated lactic acidosis mimicking ischaemic bowel","volume":"2018","author":"Ali S","year":"2018","unstructured":"Ali S, Labuschagne H, Azarov N, Hindi Z, Oud L. Metformin-associated lactic acidosis mimicking ischaemic bowel. BMJ Case Rep. 2018, 2018:10.1136\/bcr-2017-221686","journal-title":"BMJ Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2016.05.006","article-title":"Can an early diagnostic procedure of metformin-associated lactic acidosis in an emergency unit reduce mortality?","volume":"71","author":"S\u00e9mely D","year":"2016","unstructured":"S\u00e9mely D, Bennett E, Vallejo C, et al.. Can an early diagnostic procedure of metformin-associated lactic acidosis in an emergency unit reduce mortality?. Therapie. 2016, 71:605-12. 10.1016\/j.therap.2016.05.006","journal-title":"Therapie"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-013-0038-6","article-title":"The role of metformin in metformin-associated lactic acidosis (MALA): case series and formulation of a model of pathogenesis","volume":"36","author":"Duong JK","year":"2013","unstructured":"Duong JK, Furlong TJ, Roberts DM, Graham GG, Greenfield JR, Williams KM, Day RO. The role of metformin in metformin-associated lactic acidosis (MALA): case series and formulation of a model of pathogenesis. Drug Saf. 2013, 36:733-46. 10.1007\/s40264-013-0038-6","journal-title":"Drug Saf"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2015.10.014","article-title":"Metformin-associated lactic acidosis: Current perspectives on causes and risk","volume":"65","author":"DeFronzo R","year":"2016","unstructured":"DeFronzo R, Fleming GA, Chen K, Bicsak TA. Metformin-associated lactic acidosis: Current perspectives on causes and risk. Metabolism. 2016, 65:20-9. 10.1016\/j.metabol.2015.10.014","journal-title":"Metabolism"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12978","article-title":"Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: a GoDarts study","volume":"19","author":"Connelly PJ","year":"2017","unstructured":"Connelly PJ, Lonergan M, Soto-Pedre E, Donnelly L, Zhou K, Pearson ER. Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: a GoDarts study. Diabetes Obes Metab. 2017, 19:1579-86. 10.1111\/dom.12978","journal-title":"Diabetes Obes Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199630050-00003","article-title":"Clinical pharmacokinetics of metformin","volume":"30","author":"Scheen AJ","year":"1996","unstructured":"Scheen AJ. Clinical pharmacokinetics of metformin. Clin Pharmacokinet. 1996, 30:359-71. 10.2165\/00003088-199630050-00003","journal-title":"Clin Pharmacokinet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2165\/11534750-000000000-00000","article-title":"Clinical pharmacokinetics of metformin","volume":"50","author":"Graham GG","year":"2011","unstructured":"Graham GG, Punt J, Arora M, et al.. Clinical pharmacokinetics of metformin. Clin Pharmacokinet. 2011, 50:81-98. 10.2165\/11534750-000000000-00000","journal-title":"Clin Pharmacokinet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001002","article-title":"Extracorporeal treatment for metformin poisoning: systematic review and recommendations from the extracorporeal treatments in poisoning workgroup","volume":"43","author":"Calello DP","year":"2015","unstructured":"Calello DP, Liu KD, Wiegand TJ, et al.. Extracorporeal treatment for metformin poisoning: systematic review and recommendations from the extracorporeal treatments in poisoning workgroup. Crit Care Med. 2015, 43:1716-30. 10.1097\/CCM.0000000000001002","journal-title":"Crit Care Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv100","article-title":"Clinical practice guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL\/min)","volume":"30","author":"Bilo H","year":"2015","unstructured":"Bilo H, Coentr\u00e3o L, Couchoud C, et al.. Clinical practice guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR &lt;45 mL\/min). Nephrol Dial Transplant. 2015, 30:1-42. 10.1093\/ndt\/gfv100","journal-title":"Nephrol Dial Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/201634-metformin-associated-lactic-acidosis-in-individuals-without-chronic-kidney-disease-on-therapeutic-dose-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:44Z","timestamp":1707509384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/201634-metformin-associated-lactic-acidosis-in-individuals-without-chronic-kidney-disease-on-therapeutic-dose-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,12]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.48683","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,12]]}}}